Artificial heart maker Carmat completes 7 million euro capital increase


PARIS (Reuters) – Artificial heart maker Carmat, whose financial situation has been under pressure, said on Monday that it had completed a 7 million euro ($7.4 million) capital increase with several of its historical financial shareholders.
PARIS (Reuters) – Artificial heart maker Carmat, whose financial situation has been under pressure, said on Monday that it had completed a 7 million euro ($7.4 million) capital increase with several of its historical financial shareholders.
Carmat estimated it will nevertheless have to secure around 50 million euros ($52.6 million) in extra financing to cover its operations and investments until the end of October 2024.
($1 = 0.9503 euros)
(Reporting by Sudip Kar-Gupta; Editing by Jacqueline Wong)
A capital increase refers to the process of raising additional funds for a company by issuing new shares or securities. This is often done to improve the company's financial position or to fund new projects.
Corporate bonds are debt securities issued by companies to raise capital. Investors purchase these bonds, effectively lending money to the company in exchange for periodic interest payments and the return of the bond's face value at maturity.
Financing refers to the process of providing funds for business activities, making purchases, or investing. It can involve loans, credit, or issuing equity to raise capital for various purposes.
Investment is the allocation of resources, usually money, in order to generate income or profit. This can include purchasing stocks, bonds, real estate, or other assets with the expectation of future returns.
A financial shareholder is an individual or entity that owns shares in a company and has a financial interest in its performance. Shareholders may receive dividends and have voting rights in corporate decisions.
Explore more articles in the Top Stories category











